Global High-Priority Regulatory Events — February 18, 2026

19-02-2026

CMI Ltd (BSE: 517330) has intimated the scheduling of its 41st Committee of Creditors (CoC) meeting on February 20, 2026, as part of the ongoing Corporate Insolvency Resolution Process (CIRP). This indicates an advanced stage in the insolvency proceedings with multiple prior CoC meetings held, but no details on resolution plans, creditors, claims, or timelines are disclosed. The event underscores continued financial distress with no positive developments mentioned.

• ·Event filed on BSE on February 19, 2026
• ·Sector: NOT_DISCLOSED

19-02-2026

19-02-2026

Nitin Castings Limited (BSE: 508875) has intimated the floor price as determined in accordance with SEBI (Delisting of Equity Shares) Regulations, 2021. No specific floor price value, financial metrics, or performance data is disclosed in the filing. This is an informational disclosure related to the delisting process on February 19, 2026.

• ·Scrip code: 508875
• ·Source: BSE
• ·Event date: February 19, 2026
• ·Sector: technology

20-02-2026

19-02-2026

19-02-2026

19-02-2026

19-02-2026

Cardinal Infrastructure Group Inc. filed an 8-K on 2026-02-19 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also covers results of operations and financial condition (Item 2.02), creation of financial obligations (Item 2.03), unregistered sales of equity securities (Item 3.02), changes in directors or officers (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). Specific details including parties, deal terms, financial metrics, positives, negatives, or impacts are NOT_DISCLOSED.

• ·AccNo: 0001213900-26-018087
• ·File size: 10 MB
• ·Event date and filing date: 2026-02-19
• ·Sector: NOT_DISCLOSED

19-02-2026

19-02-2026

19-02-2026

BETA Technologies, Inc. filed an 8-K on 2026-02-19 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected officer, position, reason for change, or timing are provided. No quantitative financial metrics, performance comparisons, or other material data are mentioned.

19-02-2026

YETI Holdings, Inc. filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with no specific details on the affected position, type of change, or reasons provided. The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No quantitative metrics, performance comparisons, or directional indicators (positive, negative, or flat) are mentioned.

19-02-2026

19-02-2026

Figure Technology Solutions, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001628280-26-009377), reporting under Item 3.03 material modifications to rights of security holders, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no quantitative financial metrics, transaction values, or specific details on the modifications, amendments, events, or exhibits disclosed in the provided information. No positive or negative performance metrics are mentioned.

19-02-2026

Gold.com, Inc. filed an 8-K on 2026-02-19 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement terms, transaction value, financial impacts, or other metrics are provided.

19-02-2026

CVB Financial Corp filed an 8-K on 2026-02-19 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including affected positions, individuals involved, reasons for change, or any quantitative terms were provided in the filing summary. Sector is not specified.

19-02-2026

19-02-2026

Rivulet Entertainment, Inc. filed an 8-K on 2026-02-19 disclosing entry into a Material Definitive Agreement under Item 1.01, with Financial Statements and Exhibits attached under Item 9.01. This is a multi-item mandatory filing, likely timely as filed same day as event date. No details on agreement terms, transaction value, financial impacts, or strategic rationale are disclosed.

19-02-2026

ADDENTAX GROUP CORP. filed an 8-K on February 19, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties involved, financial impacts, or any quantitative metrics are disclosed in the provided filing information. This is a multi-item mandatory disclosure with no positive or negative metrics reported.

19-02-2026

Hims & Hers Health, Inc. filed a Form 8-K on 2026-02-19 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing indicates significant events but provides no specific details on transaction terms, financial impacts, or directions. No quantitative metrics, positive or negative changes, or performance comparisons are disclosed.

19-02-2026

19-02-2026

19-02-2026

Insmed Inc filed an 8-K on February 19, 2026, disclosing results of operations and financial condition under Item 2.02 and an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), with exhibits under Item 9.01. No specific details on the officer position affected, whether it was an appointment or resignation, reasons for the change, or any financial metrics from the results of operations are disclosed. No quantitative data, named executives, or scheduled events are mentioned.

19-02-2026

Integrated Wellness Acquisition Corp filed an 8-K on 2026-02-19 under Item 8.01 Other Events announcing a Merger/Acquisition event. No quantitative metrics, financial terms, parties involved, deal structure, valuation, synergies, regulatory details, or shareholder impacts are disclosed. Sector is not specified.

19-02-2026

Orion Properties Inc. filed a multi-item Form 8-K on February 19, 2026, reporting entry into a new material definitive agreement (Item 1.01) while terminating an existing material definitive agreement (Item 1.02), alongside the creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03) and Regulation FD disclosure (Item 7.01). No quantitative details such as transaction values, financial impacts, or strategic rationales were disclosed in the filing summary. Item 9.01 references financial statements and exhibits, but specifics are not provided.

19-02-2026

Lucky Strike Entertainment Corp filed an 8-K on 2026-02-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any quantitative data such as compensation amounts are provided in the filing excerpt. Sector is not specified.

19-02-2026

COMPASS Pathways plc filed a Form 8-K on 2026-02-19 reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction size, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item filing with no quantitative data or period-over-period comparisons available.

19-02-2026

Energy Services of America Corp filed an 8-K on February 19, 2026 (AccNo: 0001104659-26-017301, Size: 513 KB), disclosing under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction size, parties, financial impacts, or quantitative metrics are provided in the filing summary. This represents a multi-item filing with no disclosed positive or negative performance indicators.

19-02-2026

Paycom Software, Inc. filed an 8-K on 2026-02-19 disclosing events under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on affected positions, appointment/resignation reasons, amendments, or disclosures are provided in the filing summary. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

19-02-2026

Plumas Bancorp filed an 8-K on February 19, 2026, under Item 1.01 disclosing entry into a material definitive agreement and Item 9.01 for financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed in the provided information. This is a multi-item mandatory filing with no quantitative data or period-over-period comparisons mentioned.

19-02-2026

Bitcoin Depot Inc. filed a Form 8-K on 2026-02-19 reporting under Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the nature of modifications, amendments, disclosures, or events provided. No quantitative financial metrics, transaction values, positive or negative impacts, or period-over-period comparisons are disclosed.

19-02-2026

Old National Bancorp filed an 8-K on February 19, 2026, disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details on officers affected, reasons for changes, amendment contents, or other events are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned.

19-02-2026

NightFood Holdings, Inc. filed an 8-K on 2026-02-19 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), accompanied by Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). No quantitative metrics, parties, deal terms, or strategic details are provided in the filing summary. Sector is not specified.

19-02-2026

Lottery.com Inc. filed a Form 8-K on 2026-02-19 disclosing entry into a material definitive agreement under Item 1.01. Item 9.01 provides for financial statements and exhibits. No specific details on the agreement, transaction terms, financial impacts, or metrics are disclosed.

19-02-2026

Core Scientific, Inc. filed a Form 8-K on February 19, 2026, under Items 1.01, 5.02, and 9.01, disclosing entry into a material definitive agreement and matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No quantitative financial metrics, transaction values, personnel names, or other specific details are provided in the filing summary.

19-02-2026

AppTech Payments Corp. filed an 8-K on 2026-02-19 disclosing entry into a material definitive agreement under Item 1.01, accompanied by financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, parties, financial impact, or strategic rationale are provided. This is a multi-item mandatory filing with no quantitative metrics, comparisons, or forward-looking statements mentioned.

• ·AccNo: 0001683168-26-001173
• ·Filing size: 385 KB
• ·Sector: not specified

19-02-2026

BOK Financial Corp filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, appointment/resignation status, reasons, or timing are disclosed.

19-02-2026

Quarta-Rad, Inc. filed an 8-K on 2026-02-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial impacts are provided. No quantitative metrics, performance comparisons, or other material updates are mentioned.

19-02-2026

Black Hawk Acquisition Corp filed an 8-K on 2026-02-19 disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger or acquisition. The filing also covers creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits under Item 9.01. No specific deal terms, parties, valuations, financial metrics, positive or negative changes, or other quantitative details are disclosed.

19-02-2026

WD-40 Company filed an 8-K on February 19, 2026 (AccNo: 0000105132-26-000016, Size: 397 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, individual names, appointment or resignation status, reasons for the change, or any quantitative financial impacts are provided in the filing summary. This appears to be an informational disclosure with no mentioned positive or negative performance metrics.

19-02-2026

Texas Roadhouse, Inc. filed an 8-K on 2026-02-19 disclosing an officer change or related matter under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). Specific details including the key position affected, name of the officer, reason for change, appointment or resignation status, and any financial metrics are NOT_DISCLOSED. No quantitative data, period-over-period comparisons, or scheduled events are provided in the filing summary.

19-02-2026

FutureTech II Acquisition Corp. filed an 8-K on 2026-02-19 (AccNo: 0001493152-26-007470, Size: 255 KB) disclosing changes in its certifying accountant under Item 4.01. Item 9.01 covers financial statements and exhibits. No merger/acquisition details, financial metrics, positive or negative changes, or other quantitative data are mentioned.

19-02-2026

Sprouts Farmers Market, Inc. filed an 8-K on February 19, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 listing Financial Statements and Exhibits. No specific details on the key position affected, appointment or resignation status, reasons for the change, timing, or any quantitative data such as compensation amounts are disclosed in the provided filing summary. This appears to be a routine governance disclosure without additional context on implications.

19-02-2026

Processa Pharmaceuticals, Inc. filed an 8-K on February 19, 2026, reporting under Item 1.02 the termination of a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details, dollar values, or financial impacts from the termination were provided.

19-02-2026

Planet Green Holdings Corp. filed an 8-K on 2026-02-19 reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, which is a material negative event signaling non-compliance with exchange requirements. The filing is multi-item, also including Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No quantitative financial metrics, impacts, or other details disclosed.

19-02-2026

Armada Hoffler Properties, Inc. filed an 8-K on 2026-02-19 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year). This is a multi-item mandatory filing with no specific details on the agreement, amendments, transaction value, financial impacts, or quantitative metrics disclosed. No positive or negative metrics provided, resulting in purely informational disclosure.

19-02-2026

Applied Optoelectronics, Inc. filed an 8-K on February 19, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on the affected position, individual names, appointment or resignation status, reasons, or any quantitative metrics are disclosed.

19-02-2026

Candel Therapeutics, Inc. filed a Form 8-K on 2026-02-19 disclosing multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, quantitative metrics, transaction values, financial results, or period-over-period comparisons are disclosed in the provided filing summary. This multi-item filing signals potentially significant developments but lacks substantive content for directional assessment.

19-02-2026

First Solar, Inc. filed an 8-K on February 19, 2026, reporting entry into a material definitive agreement (Item 1.01) and termination of another material definitive agreement (Item 1.02), while also disclosing the creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03). Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, parties, or financial impacts are disclosed, resulting in mixed implications from potential strategic shifts offset by new obligations.

19-02-2026

Opus Genetics, Inc. filed a Form 8-K on February 19, 2026 (AccNo: 0001140361-26-006176), reporting under multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific quantitative metrics, transaction values, period-over-period comparisons, or financial impacts disclosed in the provided information. No positive or negative performance indicators are mentioned.

19-02-2026

Park Dental Partners, Inc. filed an 8-K on 2026-02-19 under Item 1.01 disclosing entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details, financial impacts, or period-over-period comparisons are disclosed.

• ·Accession Number: 0001104659-26-017525
• ·Filing size: 274 KB
• ·Sector: NOT_DISCLOSED

19-02-2026

DeFi Development Corp. filed an 8-K on 2026-02-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, effective dates, or any quantitative impacts are disclosed. The filing size is 260 KB with AccNo 0001213900-26-018400.

19-02-2026

PERDOCEO EDUCATION Corp filed an 8-K on 2026-02-19 disclosing an officer change event, with Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, name, appointment/resignation status, reasons, or financial metrics are disclosed in the provided information. No positive or negative metrics are mentioned.

19-02-2026

D. Boral Acquisition I Corp. filed an 8-K on 2026-02-19 under AccNo 0001213900-26-018401 (430 KB), disclosing other events under Item 8.01 related to a merger/acquisition and attaching financial statements and exhibits under Item 9.01. No specific details on deal structure, parties involved, valuation, terms, or financial metrics are provided in the filing summary. Sector is not specified.

19-02-2026

Balchem Corp filed an 8-K on February 19, 2026 (AccNo: 0001140361-26-006184, Size: 152 KB), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons, timing, or quantitative impacts are disclosed.

19-02-2026

SharonAI Holdings, Inc. filed a Form 8-K on 2026-02-19 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no further details provided on the nature of the agreement, events, or exhibits. No quantitative metrics, financial impacts, or transaction specifics are disclosed.

• ·Filing Accession Number: 0001829126-26-001479
• ·Filing size: 523 KB

19-02-2026

Synopsys Inc filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Regulation FD Disclosure under Item 7.01. No specific details on the affected officer, position, reason for change, or compensatory arrangements are provided in the available information. No quantitative metrics, performance comparisons, or other financial data mentioned.

19-02-2026

EASTMAN KODAK CO filed an 8-K on 2026-02-19 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, appointment or resignation status, reasons for change, timing, or individuals involved are provided. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

19-02-2026

Generation Income Properties, Inc. filed an 8-K on 2026-02-19 disclosing under Item 1.01 entry into a material definitive agreement. No specific details regarding the agreement's nature, parties involved, dollar value, financial terms, or strategic implications are provided in the available filing summary. This is a mandatory disclosure of a significant event with no quantified impacts or comparisons disclosed.

19-02-2026

W. P. Carey Inc. filed an 8-K on February 19, 2026 (AccNo: 0001104659-26-017544), reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction value, financial impacts, or quantitative metrics are disclosed in the provided filing information. This multi-item filing indicates potentially significant developments but lacks substantive data for directional analysis.

19-02-2026

Matthews International Corp filed an 8-K on 2026-02-19 disclosing Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on officer changes, governance amendments, voting outcomes, or any quantitative metrics such as transaction values, share counts, or percentage changes are disclosed. No positive or negative performance metrics were mentioned.

19-02-2026

Pulse Biosciences, Inc. filed an 8-K on 2026-02-19 reporting entry into a new material definitive agreement under Item 1.01 and termination of a prior material definitive agreement under Item 1.02, with exhibits provided under Item 9.01. This multi-item filing signals a potential strategic shift involving both a new commitment and the end of an existing one. Specific terms, parties, financial impacts, and strategic details are NOT_DISCLOSED.

19-02-2026

Amgen Inc filed an 8-K on 2026-02-19 under Item 1.01 disclosing entry into a Material Definitive Agreement and Item 9.01 for Financial Statements and Exhibits. No details on the agreement's nature, counterparties, terms, or financial implications are provided. No quantitative metrics, positive or negative changes, or scheduled events are mentioned.

19-02-2026

Weyerhaeuser Co filed a Form 8-K on 2026-02-19 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as key positions affected, names of individuals, reasons for the change, timing, or any quantitative financial impacts are disclosed. This is presented as a standard governance event without further context on positive or negative implications.

19-02-2026

Meritage Homes Corporation filed an 8-K on February 19, 2026 (AccNo: 0000833079-26-000016), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 8.01 reports other events, and Item 9.01 provides financial statements and exhibits. No specific details on the nature of the officer change, names, reasons, timing, or quantitative impacts are disclosed.

19-02-2026

National Bank Holdings Corp filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 refers to financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed.

19-02-2026

Viper Energy, Inc. filed an 8-K on 2026-02-19 disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, whether it was an appointment or resignation, reasons for the change, timing, or any quantitative data are disclosed. No positive or negative governance implications, board outcomes, or succession signals can be assessed due to lack of details.

19-02-2026

White Pearl Acquisition Corp. filed an 8-K on 2026-02-19 disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01, in connection with a merger/acquisition event. Specific details on deal structure, parties involved, valuation, terms, or financial impacts are NOT_DISCLOSED. No quantitative metrics, comparisons, or strategic rationale are provided in the filing summary.

19-02-2026

Performance Food Group Co filed an 8-K on February 19, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, with Item 9.01 providing financial statements and exhibits. No specific transaction details, dollar values, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed. This is a multi-item mandatory disclosure with no quantified impacts available.

19-02-2026

Park Hotels & Resorts Inc. filed an 8-K on 2026-02-19 (AccNo: 0001617406-26-000003) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), results of operations and financial condition under Item 2.02, and financial statements and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, financial metrics, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

• ·Filing size: 8 MB

19-02-2026

Rein Therapeutics, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-059545), disclosing information under Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; and Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for changes, or compensatory terms are provided in the available information. Sector is not specified.

19-02-2026

NNN REIT, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-059530, Size: 384 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the officer(s) involved, position affected, reason for change, or any quantitative metrics are NOT_DISCLOSED.

19-02-2026

GoPro, Inc. filed an 8-K on 2026-02-19 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

• ·AccNo: 0001628280-26-009818
• ·Filing size: 221 KB
• ·Sector: NOT_DISCLOSED

19-02-2026

Lifeward Ltd. filed an 8-K on February 19, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. No quantitative details such as transaction value, financial terms, or impacts were disclosed. This is a multi-item mandatory filing with limited specifics provided.

19-02-2026

Columbus Circle Capital Corp II filed an 8-K on February 19, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on affected positions, individuals involved, reasons for the change, or any quantitative impacts were disclosed. No positive or negative metrics, performance comparisons, or governance implications were provided.

• ·Filing Accession Number: 0001213900-26-018446
• ·File Size: 469 KB
• ·Sector: not specified

19-02-2026

Vanda Pharmaceuticals Inc. filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals, reasons, or quantitative impacts are disclosed.

19-02-2026

Hanover Bancorp, Inc. /MD filed an 8-K on 2026-02-19 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any financial metrics were provided. No positive or negative performance metrics were mentioned.

19-02-2026

HCW Biologics Inc. filed a Form 8-K on February 19, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 8.01 other events. No specific details on the agreement, transaction terms, financial impacts, positive or negative metrics, or other quantitative data are disclosed in the provided filing information.

19-02-2026

ManpowerGroup Inc. filed an 8-K on February 19, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided in the available information. No quantitative metrics, financial impacts, or performance comparisons are mentioned.

• ·Filing accession number: 0001193125-26-059576
• ·Filing size: 607 KB
• ·Sector: NOT_DISCLOSED

19-02-2026

Kentucky First Federal Bancorp filed an 8-K on 2026-02-19 disclosing the termination of a material definitive agreement under Item 1.02. The filing also references Item 9.01 for financial statements and exhibits. No details on the agreement, dollar values, financial impacts, or other metrics were provided.

19-02-2026

urban-gro, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001213900-26-018473) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any financial metrics are disclosed. No positive or negative metrics are mentioned.

19-02-2026

Pinnacle West Capital Corp filed a Form 8-K on February 19, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 5.02 departure of directors/officers, election/appointment, or compensatory arrangements for certain officers. Item 9.01 lists financial statements and exhibits. No quantitative details, dollar values, or specific impacts were disclosed.

19-02-2026

Avalon GloboCare Corp. filed an 8-K on 2026-02-19 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.01 completion of an acquisition or disposition of assets. Item 9.01 includes financial statements and exhibits. No specific transaction details, financial metrics, parties, values, or performance indicators are disclosed.

19-02-2026

Sow Good Inc. filed a multi-item Form 8-K on February 19, 2026, disclosing entry into a material definitive agreement (Item 1.01), departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03). Item 9.01 references financial statements and exhibits. No quantitative details, transaction values, personnel names, or specific changes are disclosed.

• ·AccNo: 0001829126-26-001486
• ·File Size: 531 KB

19-02-2026

AMERICAN REBEL HOLDINGS INC filed a Form 8-K on February 19, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, alongside Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). This multi-item filing indicates a potentially strategic agreement offset by potentially dilutive equity sales, but specific terms, values, and impacts are NOT_DISCLOSED. No financial metrics, period-over-period changes, or guidance updates are mentioned.

19-02-2026

Getty Realty Corp (/MD/) filed an 8-K on February 19, 2026 (AccNo: 0001193125-26-059712), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement parties, terms, transaction value, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material contract event.

19-02-2026

Spartacus Acquisition Corp. II filed an 8-K on 2026-02-19 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) related to a Merger/Acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, synergies, regulatory pathway, or shareholder impacts are disclosed. No quantitative metrics, positive or negative changes, or scheduled events are mentioned in the provided filing information.

19-02-2026

NexPoint Diversified Real Estate Trust filed an 8-K on 2026-02-19 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. No quantitative details such as transaction value, terms, parties, or financial impacts are disclosed in the provided filing summary. This multi-item filing signals a potentially significant financing event, but lacks specifics for impact assessment.

19-02-2026

Willow Lane Acquisition Corp. II filed an 8-K on February 19, 2026, disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger or acquisition as a SPAC. Additional disclosures include unregistered sales of equity securities (Item 3.02), departures or elections of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific transaction parties, valuation, financial metrics, or performance comparisons are disclosed.

19-02-2026

VSEE Health, Inc. filed an 8-K on February 19, 2026 (AccNo: 0001185185-26-000625), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement terms, parties, value, financial impacts, or other metrics are disclosed in the provided information. This is a multi-item mandatory disclosure with no quantitative data or performance metrics provided.

19-02-2026

Expeditors International of Washington Inc filed an 8-K on 2026-02-19 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer, position, appointment/resignation, reasons, or financial metrics are disclosed.

19-02-2026

Camden Property Trust filed an 8-K on 2026-02-19 disclosing entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03, which is a multi-item filing including Financial Statements and Exhibits under Item 9.01. No specific details on the agreement, transaction value, terms, or financial impacts are disclosed. This appears to be a mandatory disclosure of material events.

19-02-2026

Artiva Biotherapeutics, Inc. filed a Form 8-K on 2026-02-19 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names, positions affected, reasons for change, timing, or any quantitative financial metrics are provided in the available information. No positive or negative performance metrics, comparisons, or impacts are mentioned.